203 related articles for article (PubMed ID: 9734197)
1. [If I were to wake-up clumsy and trembling...(or how to begin treatment of Parkinson disease].
Linazasoro G
Neurologia; 1998; 13(6):265-70. PubMed ID: 9734197
[No Abstract] [Full Text] [Related]
2. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
Dubois B; Montastruc JL
Rev Neurol (Paris); 1996 Feb; 152(2):103-5. PubMed ID: 8761616
[No Abstract] [Full Text] [Related]
3. Selegiline slows the progression of the symptoms of Parkinson disease.
Pålhagen S; Heinonen E; Hägglund J; Kaugesaar T; Mäki-Ikola O; Palm R;
Neurology; 2006 Apr; 66(8):1200-6. PubMed ID: 16540603
[TBL] [Abstract][Full Text] [Related]
4. Deprenyl and levodopa and Parkinson's disease progression.
Fowler JS; Fazzini E; Volkow ND
Ann Neurol; 1996 Aug; 40(2):267-8. PubMed ID: 8773616
[No Abstract] [Full Text] [Related]
5. Treatment challenges in early stage Parkinson's disease.
Tetrud J
Neurol Clin; 2004 Oct; 22(3 Suppl):S19-33. PubMed ID: 15501364
[No Abstract] [Full Text] [Related]
6. Parkinson's disease: diagnosis, pathology, and treatment.
Sethi KD
J Med Assoc Ga; 1997 Apr; 86(2):89-96. PubMed ID: 9114653
[No Abstract] [Full Text] [Related]
7. Deprenyl in Parkinson's disease.
Korczyn AD; Nisipeanu P
Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617
[No Abstract] [Full Text] [Related]
8. Deprenyl's neuroprotective action remains unresolved.
van Hilten JJ; Bloem BR; Klaassen AA
Ann Neurol; 1996 Aug; 40(2):266-7. PubMed ID: 8773615
[No Abstract] [Full Text] [Related]
9. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
[TBL] [Abstract][Full Text] [Related]
10. Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality.
Aaltonen H; Kilkku O; Heinonen E; Mäki-Ikola O
BMJ; 1998 Dec; 317(7172):1586-7. PubMed ID: 9890764
[No Abstract] [Full Text] [Related]
11. [Parkinson disease].
Moore AP; Clarke CE
Praxis (Bern 1994); 2001 Jun; 90(23):1041-6. PubMed ID: 11447724
[No Abstract] [Full Text] [Related]
12. [Drug therapy of Parkinson's disease].
Myllylä V
Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076
[No Abstract] [Full Text] [Related]
13. Selegiline and excess mortality.
Oakes D
Clin Neuropharmacol; 1997 Dec; 20(6):542. PubMed ID: 9403228
[No Abstract] [Full Text] [Related]
14. Levodopa therapy for Parkinson's disease: challenges and future prospects.
Olanow CW; Lees A; Obeso J
Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
[No Abstract] [Full Text] [Related]
15. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(3):161-6. PubMed ID: 2868512
[No Abstract] [Full Text] [Related]
16. Parkinson's disease.
Clarke C; Moore AP
Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
[No Abstract] [Full Text] [Related]
17. Parkinson's disease.
Imke S
Adv Nurse Pract; 1998 Jan; 6(1):24-8. PubMed ID: 9495941
[No Abstract] [Full Text] [Related]
18. [Therapy of idiopathic Parkinson syndrome 1817 to 2001. A success story?].
Ludin HP
Praxis (Bern 1994); 2001 Jun; 90(23):1009-14. PubMed ID: 11447720
[TBL] [Abstract][Full Text] [Related]
19. Levodopa unresponsive symptoms in Parkinson disease.
Sethi K
Mov Disord; 2008; 23 Suppl 3():S521-33. PubMed ID: 18781679
[TBL] [Abstract][Full Text] [Related]
20. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
